Christchurch Medicines Information Service

  • Home
  • About us
  • Enquiries
  • Bulletins
  • Medicines in specific patient groups
    • Medicines and liver impairment
    • Medicines and renal impairment
    • Medicines and elderly
    • Medicines and breastfeeding
    • Medicines and pregnancy
  • Resources
    • Complementary & Alternative Medicines
    • Therapeutic Drug Monitoring
    • Useful links
  • Medicines and COVID-19
Filter results:

Bulletins - New medicine

Filter by category:
AdministrationAdverse drug reactionsCannabis-based productsComplementary and Alternative Medicines (CAMs)Drug comparisonsExtremes of Age – paediatric and elderlyInteractionsNew medicineOtherPharmacokineticPregnancy/Breastfeeding

Levomepromazine 25 mg and 100 mg tablets – important note regarding product change - February 26, 2020

Key points The current NZ Sanofi levomepromazine (Nozinan®) 25 mg and 100 mg tablets will be replaced with Swiss Sanofi Nozinan® formulations temporarily from 1st March 2020. They are not bioequivalent. Dose equivalency is 1 x NZ tablet ≈ 0.75 x Swiss tablet. All prescriptions sho...

Vildagliptin for diabetes – funded in NZ - March 29, 2019

There are over 240,000 people in NZ currently diagnosed with diabetes mellitus (mostly type 2), and possibly another 100,000 undiagnosed. In October 2018, vildagliptin became the first dipeptidyl peptidase-4 (DPP-4) inhibitor funded in NZ. It is one of a number of DPP-4 inhibitors used internatio...
CopyrightPrivacyDisclaimerFAQs